KEQU posts sharp Q2 sales growth, driven by strong backlog and Nu Aire, but earnings decline amid project timing volatility and higher costs.
KEQU earns an upgrade to "Outperform" as Nu Aire integration drives sales growth, margins expand and a record backlog boosts visibility, offsetting tariff risks with proactive inventory strategies.
KEQU posts strong Q4 and FY25 results, driving a 47% stock surge as sales jump and the Nu Aire acquisition boosts growth momentum.
| Household Durables Industry | Consumer Discretionary Sector | Thomas David Hull III CEO | NASDAQ (NMS) Exchange | 492854104 CUSIP |
| US Country | 1,006 Employees | 24 Sep 2019 Last Dividend | 7 Jan 1985 Last Split | 25 Feb 1992 IPO Date |
Kewaunee Scientific Corporation is a seasoned player in the design, manufacture, and installation of a broad range of furniture and infrastructure products, tailored primarily for laboratory, healthcare, and technical spaces. Founded in 1906 and headquartered in Statesville, North Carolina, the company stands on over a century of expertise. Kewaunee operates through two main segments: Domestic and International, serving a diverse clientele that spans the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and healthcare sectors. Products from Kewaunee are distributed mainly through an extensive network of dealers, its own subsidiaries, and a national distributor, marking its footprint in both the domestic and global markets.
Kewaunee Scientific Corporation's product portfolio is comprehensive, catering to a variety of needs in lab, healthcare, and technical environments:
These products find their application across a spectrum of settings, from general science laboratories in academic institutions to more specialized facilities in the pharmaceutical, biotechnology, and industrial sectors. Kewaunee's technical products cater to the needs of the electronics manufacturing sector and computer and networking furniture users, emphasizing the company's adaptability to various market demands.